The future of global health lies in patient-centered innovation.

We are committed to expanding patient access to affordable biologic & complex medicines worldwide.
More about us
8
+

Programs in Development

Explore Our Pipeline

Latest Press Release

Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)
More News
Products and pipeline

Development Capabilities

Read more
About us

Who We Are

We are a diverse team brought together by a shared purpose.
With state-of-the-art facilities in the US and India, we are equipped to develop and manufacture biologics at the highest quality standards.
Kashiv's Lab Imagery

300

+

Employees
Of which over half hold advanced degrees
Kashiv's Lab Imagery
Kashiv's Lab ImageryKashiv's Lab Imagery

Our Approach

We believe that a vertically integrated approach, from R&D through fill and finish manufacturing, gives us the focus, scale and speed needed to achieve our mission.
More about us
Kashiv Offices In Chicago